Non-OpeRative MANagement of Rectal Cancer Patients
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study is a single-center, open, prospective, single-treatment trial (pilot study). This
study aims to analyze the treatment results after receiving capecitabine adjuvant
chemotherapy for 4 months after non-surgical treatment in patients who had completed and
could have clinical complete remission with capecitabine preoperative chemoradiotherapy with
capecitabine for mid-to-lower rectal cancer and to investigate the feasibility of
non-surgical treatment.